Prospective Breast Cancer Biospecimen Collection

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
Thomas Jefferson University
Study ID
NCT04074720
Status
Recruiting
Apply to this trial

Conditions

  • Breast Cancer
  • Carcinoma in Situ of the Breast
  • Invasive Breast Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Tissue Sample collection — PROCEDURE
    Tissue sample collected following standard of care procedure patient was already scheduled to have
  • Blood Sample Collection — OTHER
    A one time sample of blood will be collected on day of standard of care procedure
  • Rectal Swab — OTHER
    optional rectal swab may be collected on day of standard of care procedure

Study Details

Tissue will be procured during a standard of care procedure the patient will already be scheduled to undergo. A one time blood draw will be performed at this time and an optional rectal swab for biome analysis may occur. Follow Up will only consist of chart review to determine date of recurrence, metastases, and/or death

Key Dates

Start date
May 10, 2018
Status verified
Nov 2025
Primary completion
Jul 1, 2028
Completion
Jul 1, 2028

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Group 1: Newly Diagnosed Breast Cancer Patients
    Tissue will be procured during a standard of care procedure the patient will already have scheduled. A one time blood draw will be performed at this time and an optional rectal swab for biome analysis may occur. Follow up will only consist of chart review to determine date of recurrence, metastases, and/or death.
  • Arm: Group 2: Patients with Brain Metastases from Primary Breast Cancer
    The brain metastasis specimen experiments will use tissue from 36 patients (12 per subtype: estrogen positive, Her-neu-2 positive, and triple negative). Tissue will be procured during a standard of care procedure the patient will already have scheduled. A one time blood draw will be performed at this time and an optional rectal swab for biome analysis may occur. Follow up will only consist of chart review to determine date of recurrence, metastases, and/or death.

Primary Outcome Measure

Tumor biomarker identification [ Time Frame: Up to 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Sidney Kimmel Cancer Center at Thomas Jefferson UniversityPhiladelphiaPennsylvania19107
Nicole Simone
[email protected]
2159556702

Find similar trials in Philadelphia, PA

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Sidney Kimmel Cancer Center at Thomas Jefferson University· Philadelphia, PA

Related Studies